Showing results (1801-1810 of 2,739) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|March 31, 2010
Advances in pharmacogenomics technologiesC Ramana Bhasker, Gary HardimanPharmacogenomics|March 31, 2010
Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometryMatteo Falzoi, Alessandra Mossa, Elena Congeddu, et al.Pharmacogenomics|May 28, 2010
CD40-1C>T polymorphism (rs1883832) is associated with brain vessel reocclusion after fibrinolysis in ischemic strokeAlberto del Río-Espínola, Israel Fernández-Cadenas, Marta Rubiera, et al.Pharmacogenomics|May 28, 2010
Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sampleCarolin Opgen-Rhein, Eva Janina Brandl, Daniel J Müller, et al.Pharmacogenomics|May 28, 2010
Drug transporter pharmacogenetics in nucleoside-based therapiesEkaitz Errasti-Murugarren, Marçal Pastor-AngladaPharmacogenomics|April 27, 2010
HTR2C promoter polymorphisms are associated with risperidone efficacy in Chinese female patientsBao-Cheng Liu, Jing Zhang, Lei Wang, et al.Pharmacogenomics|April 27, 2010
Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesityDorit Schleinitz, Solveig Carmienke, Yvonne Böttcher, et al.Pharmacogenomics|October 24, 2006
Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolismKristine Glunde, Natalie J SerkovaPharmacogenomics|June 15, 2007
Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitroZeruesenay Desta, Tanja Saussele, Bryan Ward, et al.Pharmacogenomics|June 15, 2007
Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patientsSuman Lal, Zee Wan Wong, Srinivasa Rao Jada, et al.Pageof 274